{
    "organizations": [],
    "uuid": "6859e48aac4c918cfc6d73ce01e829b03b200ec7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-mithra-analysis-across-a-range-of/brief-mithra-analysis-across-a-range-of-parameters-points-to-limited-hemostatic-impact-for-estelle-idUSFWN1QQ05U",
    "ord_in_thread": 0,
    "title": "BRIEF-Mithra Analysis Across A Range Of Parameters Points To Limited Hemostatic Impact For Estelle",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - MITHRA PHARMACEUTICALS SA:\n* ANALYSIS ACROSS A RANGE OF PARAMETERS POINTS TO LIMITED HEMOSTATIC IMPACT FOR ESTELLEÂ®,\n* RESULTS CORROBORATE EARLIER FINDINGS AND FURTHER DELINEATE UNIQUE SAFETY PROFILE OF ESTELLE Source text : bit.ly/2tpdKwd Further company coverage: (Gdynia Newsroom)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-08T14:41:00.000+02:00",
    "crawled": "2018-03-09T14:47:02.029+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "mithra",
        "pharmaceutical",
        "sa",
        "analysis",
        "across",
        "range",
        "parameter",
        "point",
        "limited",
        "hemostatic",
        "impact",
        "result",
        "corroborate",
        "earlier",
        "finding",
        "delineate",
        "unique",
        "safety",
        "profile",
        "estelle",
        "source",
        "text",
        "company",
        "coverage",
        "gdynia",
        "newsroom",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}